期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 53, 期 6, 页码 2510-2520出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm901689v
关键词
-
Modification oldie partial dopamine type 2 receptor (D-2) agonist 3-(1-benzylpiperidin-4-yl)phenol (9a) generated a series of novel functional D-2 antagonists with fast-off kinetic properties. A representative of this series, pridopidine (4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine; ACR16, 12b), bound competitively with low affinity to D, in vitro, without displaying properties essential for interaction with D-2 in the inactive state, thereby allowing receptors to rapidly regain responsiveness. In vivo, neurochemical effects of 12b were similar to those of D-2 antagonists, and in a model of locomotor hyperactivity, 12b dose-dependently reduced activity. In contrast to classic D-2 antagonists, 12b increased spontaneous locomotor activity in partly habituated animals. The agonist-like kinetic profile of 12b, combined with its lack of intrinsic activity, induces a functional state-dependent D, antagonism that can vary with local, real-time dopamine concentration fluctuations around distinct receptor populations. These properties may contribute to its unique dopaminergic stabilizer characteristics, differentiating 12b from D-2 antagonists and partial D-2 agonists.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据